←Back to Expert Scholars
Translational Medicine / 转化医学Hereditary Cancer, PARP Inhibitors
Susan Domchek
MD
🏢University of Pennsylvania🌐USA
Basser Professor in Oncology
105
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Susan Domchek directs the Basser Center for BRCA at Penn and led pivotal trials including OlympiA establishing adjuvant olaparib for germline BRCA-mutated breast cancer. Her research spans prevention, surveillance, and targeted therapy. She is a past ASCO Scientific Program chair.
Share:
🧪Research Fields 研究领域
BRCA1
BRCA2
PARP inhibitors
OlympiA trial
hereditary breast cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Susan Domchek 的研究动态
Follow Susan Domchek's research updates
留下邮箱，当我们发布与 Susan Domchek（University of Pennsylvania）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment